- Conditions
- Short Gut Syndrome
- Interventions
- Sucrase, Placebo
- Drug · Other
- Lead sponsor
- University of Miami
- Other
- Eligibility
- Not listed
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 2
- States / cities
- Miami, Florida
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Congenital Sucrase-Isomaltase Deficiency
- Interventions
- Sucrose Hydrogen Methane Breath Test
- Diagnostic Test
- Lead sponsor
- QOL Medical, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 211 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Culver City, California
- Conditions
- Congenital Sucrase-isomaltase Deficiency (CSID)
- Interventions
- Not listed
- Lead sponsor
- QOL Medical, LLC
- Industry
- Eligibility
- Up to 18 Years
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 19
- States / cities
- Los Angeles, California • Oakland, California • Aurora, Colorado + 16 more
- Conditions
- Fructan Intolerance
- Interventions
- Sacrosidase Oral Solution, Placebo
- Drug
- Lead sponsor
- QOL Medical, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency
- Interventions
- Sucraid (sacrosidase) Oral Solution 8500 IU/mL
- Biological
- Lead sponsor
- QOL Medical, LLC
- Industry
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 312 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 20
- States / cities
- Los Angeles, California • Oakland, California • Coral Gables, Florida + 13 more